These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26003773)

  • 21. Rescheduling of hydrocodone combination products.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):101-2. PubMed ID: 25296260
    [No Abstract]   [Full Text] [Related]  

  • 22. Post-tonsillectomy pain management in children: can we do better?
    Bean-Lijewski JD; Kruitbosch SH; Hutchinson L; Browne B
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):545-51. PubMed ID: 17903568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nondrug Interventions Reduce Pain and Opioid Use After Total Knee Arthroplasty.
    Cibrian K
    Am J Nurs; 2017 Nov; 117(11):62. PubMed ID: 29076861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximum daily dose of hydrocodone.
    Nerenberg DM; Fudin J
    Am J Health Syst Pharm; 2010 Oct; 67(19):1588-9. PubMed ID: 20852155
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of 2 analgesic regimens for the control of postoperative periodontal discomfort.
    Tucker PW; Smith JR; Adams DF
    J Periodontol; 1996 Feb; 67(2):125-9. PubMed ID: 8667132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments toward the safer use of opioids, with a focus on hydrocodone.
    Covvey JR
    Res Social Adm Pharm; 2015; 11(6):901-8. PubMed ID: 25769501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-release hydrocodone (Hysingla ER) for pain.
    Med Lett Drugs Ther; 2015 May; 57(1468):71-2. PubMed ID: 25941956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
    Taber L; Lynch SY; He E; Ripa SR
    Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cigarette smoking on hydrocodone efficacy in chronic pain patients.
    Ackerman WE
    J Ark Med Soc; 2012 Oct; 109(5):90-3. PubMed ID: 23061240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
    Gan TJ; Joshi GP; Zhao SZ; Hanna DB; Cheung RY; Chen C
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1194-207. PubMed ID: 15352969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid rotation: what is the rush?
    Passik SD
    Pain Med; 2012 Apr; 13(4):487-8. PubMed ID: 22497723
    [No Abstract]   [Full Text] [Related]  

  • 32. A review of opioids for in-hospital pain management.
    Viscusi ER; Pappagallo M
    Hosp Pract (1995); 2012 Feb; 40(1):149-59. PubMed ID: 22406890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
    Zacny JP; Gutierrez S
    Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic efficacy of a combination of hydrocodone with ibuprofen in postoperative pain.
    Wideman GL; Keffer M; Morris E; Doyle RT; Jiang JG; Beaver WT
    Clin Pharmacol Ther; 1999 Jan; 65(1):66-76. PubMed ID: 9951432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic pain, addiction, and Zohydro.
    Olsen Y; Sharfstein JM
    N Engl J Med; 2014 May; 370(22):2061-3. PubMed ID: 24758596
    [No Abstract]   [Full Text] [Related]  

  • 36. 12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
    Wen W; Taber L; Lynch SY; He E; Ripa S
    J Opioid Manag; 2015; 11(4):339-56. PubMed ID: 26312961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to set boundaries with chronic pain patients.
    Cosio D
    J Fam Pract; 2014 Mar; 63(3 Suppl):S3-8. PubMed ID: 24701609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential.
    Hale ME; Ma Y; Malamut R
    J Opioid Manag; 2016; 12(2):139-47. PubMed ID: 27194199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feeling the pain.
    Nuzback K
    Tex Med; 2015 Jan; 111(1):37-41. PubMed ID: 25624026
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey.
    Smith MY; Haddox JD; Di Marino ME
    J Pain Palliat Care Pharmacother; 2007; 21(3):5-17. PubMed ID: 18032351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.